Biolog, Inc

CIK:0001462566|SEC Filings

Statements of Operations (USD $)	12 Months Ended
Statements of Operations (USD $)	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Income	$ 7,642us-gaap_Revenues	$ 7,698us-gaap_Revenues
Cost of services	(8,373)us-gaap_CostOfServices	(9,138)us-gaap_CostOfServices
Gross Loss	(731)us-gaap_GrossProfit	(1,440)us-gaap_GrossProfit
Operating Expenses:
Accounting and bookkeeping	12,400us-gaap_ProfessionalFees	15,400us-gaap_ProfessionalFees
Other general and administrative expenses	15,740	9,832
Total Operating Expenses	28,140us-gaap_OperatingExpenses	25,232us-gaap_OperatingExpenses
Operating Loss	(28,871)us-gaap_OperatingIncomeLoss	(26,672)us-gaap_OperatingIncomeLoss
Other Expense:
Interest Expense	(5,826)us-gaap_InterestExpense	(4,740)us-gaap_InterestExpense
Net Loss	$ (34,697)us-gaap_NetIncomeLoss	$ (31,412)us-gaap_NetIncomeLoss
Basic and diluted net loss per common share	$ 0.00us-gaap_EarningsPerShareBasicAndDiluted	$ 0.00us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding	40,436,740	40,436,740

Statements of Cash Flows (USD $)	12 Months Ended
Statements of Cash Flows (USD $)	Dec. 31, 2014	Dec. 31, 2013
Statement of Cash Flows [Abstract]
Net Loss	$ (34,697)us-gaap_NetIncomeLoss	$ (31,412)us-gaap_NetIncomeLoss
Depreciation	1,000us-gaap_Depreciation	1,000us-gaap_Depreciation
Changes in operating assets and liabilities:
Accounts receivable	287	258
Accounts payable and accrued expenses	3,254	19,973
Accounts payable - related party	3,900	5,400
Interest payable - related party	5,305biol_InterestPayableRelatedParty	4,740biol_InterestPayableRelatedParty
Net Cash Used in Operating Activities	(20,951)	(41)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from loans	9,180us-gaap_ProceedsFromNotesPayable
Proceeds from convertible notes - related parties	12,250us-gaap_ProceedsFromRelatedPartyDebt
Net Cash Provided by Financing Activities	21,430
Net increase (decrease) in cash	479	(41)
Cash at beginning of period	109	150
Cash at end of period	588	109
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for Interest
Cash paid during the period for Income taxes

Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 588	$ 109
Accounts receivable	160us-gaap_AccountsReceivableNetCurrent	447us-gaap_AccountsReceivableNetCurrent
Total Current Assets	748us-gaap_AssetsCurrent	556us-gaap_AssetsCurrent
Property and Equipment:
Payphone equipment	5,000us-gaap_PropertyPlantAndEquipmentGross	5,000us-gaap_PropertyPlantAndEquipmentGross
Less accumulated depreciation	(4,333)	(3,333)
Net Property and Equipment	667us-gaap_PropertyPlantAndEquipmentNet	1,667us-gaap_PropertyPlantAndEquipmentNet
TOTAL ASSETS	1,415us-gaap_Assets	2,223us-gaap_Assets
Current Liabilities:
Accounts payable and accrued expense	77,447	74,193
Accounts payable to related parties	23,600	19,700
Convertible notes to related parties	71,500	59,250
Interest payable to related parties	18,410us-gaap_InterestPayableCurrent	13,105us-gaap_InterestPayableCurrent
Note payable	9,180us-gaap_NotesPayableCurrent
Total Current Liabilities	200,137us-gaap_LiabilitiesCurrent	166,248us-gaap_LiabilitiesCurrent
Stockholders' Deficit:
Preferred Stock
Common Stock	40,440us-gaap_CommonStockValue	40,440us-gaap_CommonStockValue
Additional paid-in capital	(2,123)us-gaap_AdditionalPaidInCapital	(2,123)us-gaap_AdditionalPaidInCapital
Accumulated deficit	(237,039)	(202,342)
Total Stockholders' Deficit	(198,722)us-gaap_StockholdersEquity	(164,025)us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,415	$ 2,223